174 related articles for article (PubMed ID: 26984141)
21. CotH3 mediates fungal invasion of host cells during mucormycosis.
Gebremariam T; Liu M; Luo G; Bruno V; Phan QT; Waring AJ; Edwards JE; Filler SG; Yeaman MR; Ibrahim AS
J Clin Invest; 2014 Jan; 124(1):237-50. PubMed ID: 24355926
[TBL] [Abstract][Full Text] [Related]
22. Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine.
Liu M; Lin L; Gebremariam T; Luo G; Skory CD; French SW; Chou TF; Edwards JE; Ibrahim AS
PLoS Pathog; 2015 May; 11(5):e1004842. PubMed ID: 25974051
[TBL] [Abstract][Full Text] [Related]
23. Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.
Shirazi F; Pontikos MA; Walsh TJ; Albert N; Lewis RE; Kontoyiannis DP
Antimicrob Agents Chemother; 2013 Sep; 57(9):4360-8. PubMed ID: 23817366
[TBL] [Abstract][Full Text] [Related]
24. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.
Liu M; Spellberg B; Phan QT; Fu Y; Fu Y; Lee AS; Edwards JE; Filler SG; Ibrahim AS
J Clin Invest; 2010 Jun; 120(6):1914-24. PubMed ID: 20484814
[TBL] [Abstract][Full Text] [Related]
25. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
mBio; 2020 Jun; 11(3):. PubMed ID: 32487760
[TBL] [Abstract][Full Text] [Related]
26. Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
Lewis RE; Albert ND; Kontoyiannis DP
Antimicrob Agents Chemother; 2014 Nov; 58(11):6767-72. PubMed ID: 25182639
[TBL] [Abstract][Full Text] [Related]
27. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
Gebremariam T; Wiederhold NP; Alqarihi A; Uppuluri P; Azie N; Edwards JE; Ibrahim AS
J Antimicrob Chemother; 2017 Feb; 72(2):462-466. PubMed ID: 27798213
[TBL] [Abstract][Full Text] [Related]
28. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis.
Ibrahim AS; Gebremariam T; Lin L; Luo G; Husseiny MI; Skory CD; Fu Y; French SW; Edwards JE; Spellberg B
Mol Microbiol; 2010 Aug; 77(3):587-604. PubMed ID: 20545847
[TBL] [Abstract][Full Text] [Related]
29. Effects of Photodynamic Inactivation on the Growth and Antifungal Susceptibility of Rhizopus oryzae.
Liu Z; Tang J; Sun Y; Gao L
Mycopathologia; 2019 Apr; 184(2):315-319. PubMed ID: 30689142
[TBL] [Abstract][Full Text] [Related]
30. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae.
Kok J; Gilroy N; Halliday C; Lee OC; Novakovic D; Kevin P; Chen S
J Infect; 2007 Sep; 55(3):e33-6. PubMed ID: 17624436
[TBL] [Abstract][Full Text] [Related]
31. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
Spreghini E; Orlando F; Giannini D; Barchiesi F
J Antimicrob Chemother; 2010 Oct; 65(10):2158-63. PubMed ID: 20667887
[TBL] [Abstract][Full Text] [Related]
33. Unravelling the antifungal mode of action of curcumin by potential inhibition of CYP51B: A computational study validated in vitro on mucormycosis agent, Rhizopus oryzae.
Prajapati J; Rao P; Poojara L; Goswami D; Acharya D; Patel SK; Rawal RM
Arch Biochem Biophys; 2021 Nov; 712():109048. PubMed ID: 34600893
[TBL] [Abstract][Full Text] [Related]
34. Lipophilic statins inhibit growth and reduce invasiveness of human endometrial stromal cells.
Sokalska A; Hawkins AB; Yamaguchi T; Duleba AJ
J Assist Reprod Genet; 2019 Mar; 36(3):535-541. PubMed ID: 30554393
[TBL] [Abstract][Full Text] [Related]
35. Molecular Confirmation of the Linkage between the
Macedo D; Leonardelli F; Dudiuk C; Theill L; Cabeza MS; Gamarra S; Garcia-Effron G
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891608
[No Abstract] [Full Text] [Related]
36. How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Lewis RE; Lortholary O; Spellberg B; Roilides E; Kontoyiannis DP; Walsh TJ
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S67-72. PubMed ID: 22247448
[TBL] [Abstract][Full Text] [Related]
37. Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats.
Shahrezaee M; Oryan A; Bastami F; Hosseinpour S; Shahrezaee MH; Kamali A
Endocrine; 2018 Apr; 60(1):138-150. PubMed ID: 29372484
[TBL] [Abstract][Full Text] [Related]
38. A Comprehensive in vitro and in silico Assessment on Inhibition of CYP51B and Ergosterol Biosynthesis by Eugenol in Rhizopus oryzae.
Prajapati J; Rao P; Poojara L; Acharya D; Patel SK; Goswami D; Rawal RM
Curr Microbiol; 2022 Dec; 80(1):47. PubMed ID: 36538133
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.
Gebremariam T; Alkhazraji S; Lin L; Wiederhold NP; Garvey EP; Hoekstra WJ; Schotzinger RJ; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652241
[TBL] [Abstract][Full Text] [Related]
40. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
